ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ELDN vs NATR // ALTMAN Z-SCORE & DEBT/EQUITY

Eledon Pharmaceuticals Inc. (NASDAQ) VS. Nature's Sunshine Products Inc. (NASDAQ) • 15-METRIC TALLY: ELDN 2 — NATR 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ELDN VS. NATR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ELDN NATR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 72.40% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 28.90% -63.90 NATR /roic <GO>
EV/EBITDA & P/E Valuation — 4.0x — TIE /valuation <GO>
Free Cash Flow Yield — 13.35% — TIE /fcf-yield <GO>
Operating Margin — 5.20% — TIE /operating-margins <GO>
Net Profit Margin — 4.10% — TIE /net-margins <GO>
Revenue Growth (YoY) — 5.70% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — 4.33 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 8/9 -7.00 NATR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.0 33.7 +17.30 ELDN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 10.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $212.9M $211.5M $1.4M ELDN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ELDN REV NATR REV ELDN GROSS % NATR GROSS % ELDN FCF NATR FCF
FY 2025 $71.0M $480.1M — 72.4% -$62.3M $28.8M
FY 2024 $74.5M $454.4M — 71.5% -$47.3M $14.3M
FY 2023 $120.4M $445.3M — — -$39.5M $41.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ELDN // BETA —
NATR // BETA —